Evidence map›Paper›PMID 36769066›Full record

ArticleInternational journal of molecular sciences2023

Synthesis, In Silico Study, Antibacterial and Antifungal Activities of

Melanny Ika Sulistyowaty, Galih Satrio Putra, Tutuk Budiati, Anastasia Wheni Indrianingsih, Farida Anwari, Dini Kesuma, Katsuyoshi Matsunami, Takayasu Yamauchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melanny Ika SulistyowatyDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.ORCID 0000-0002-9510-6822
Galih Satrio PutraDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, Malang 65151, Indonesia.ORCID 0000-0003-4192-3621
Tutuk BudiatiFaculty of Pharmacy, Widya Mandala Catholic University, Surabaya 60265, Indonesia.
Anastasia Wheni IndrianingsihResearch Center for Food Technology and Processing, National Research and Innovation Agency (BRIN), Yogyakarta 55861, Indonesia.
Farida AnwariMedical Laboratory Science, University of Anwar Medika, Sidoarjo 61262, Indonesia.
Dini KesumaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Surabaya, Surabaya 60293, Indonesia.
Katsuyoshi MatsunamiGraduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan.ORCID 0000-0002-8034-0253
Takayasu YamauchiFaculty of Pharmaceutical Science, Hoshi University, 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan.

Funding

Airlangga University PUF year of 2016
6 · The paper itself

Abstract

Antibiotic and antifungal resistance problems have been prevalent in recent decades. One of the efforts to solve the problems is to develop new medicines with more potent antibacterial and antifungal activity.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsMicrobial Sensitivity TestsMolecular Docking SimulationStructure-Activity RelationshipAnti-Bacterial AgentsAntifungal Agents2QZX3HAVantibacterialantifungalin silicoN-phenylbenzamides derivativessynthesis

Identifiers

PMID36769066
PMCPMC9917131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.